Asent
Membership Organizations · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
230 Kings Hwy E Pmb 245, Haddonfield, Ne...Phone Number
(833) 273-6800Website
www.asent.orgRevenue
<$5 MillionIndustry
About Asent
Asent Org Chart
Is Asent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Asent had a recent Job posting/layoffs
Product Launch: Get notified when Asent launches new products
Check out if Asent is spiking on competitors!
Funding: Get notified immidiatlly once Asent has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Asent recently announced quarterly report
Check if Asent has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Asent
Asent, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Asent as Masked Content
Find 3 more new buyers
Compare Similar Companies to Asent
Compare insights from companies similar to Asent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Asent is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Asent is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Asent.
Asent Tech Stack
A closer look at the technologies used by Asent
Asent News & Media
Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
BHV-7000 differs pharmacologically and structurally from other known Kv7 compounds in development BHV-7000 demonstrates potent anti-seizure activity without effects on neurobehavior in preclinical models BHV-7000 CNS side effect profile in Phase 1 compares favorably to anti-seizure...Athira Pharma Presents Preclinical Data of Fosgonimeton (ATH-1017) and ATH-1020 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Active metabolite of fosgonimeton (ATH-1017) enhances the HGF/MET system, resulting in neurotrophic and procognitive effectsNeuroSense Therapeutics to Present at American Society for Experimental Neurotherapeutics Annual Meeting on March 3rd
CAMBRIDGE, Mass., Feb. 24, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced that Dr. Shiran Zimri, the Company's Head of Scientific Programs, will deliver a presentation...Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Oral presentation on neurotrophic and procognitive properties of the active metabolite of fosgonimeton in preclinical models
Top Membership Organizations Companies
Frequently Asked Questions Regarding Asent
ASENT is an independent non-profit organization established in 1997, aimed at facilitating the development of new therapies for patients with neurological disorders. The organization promotes scientific exchanges and dialogue among stakeholders in neurotherapeutics, while also providing education, training, and publishing a journal for healthcare p... Read More